CobaltIP-faceted-search-demo
Match Document Document Title
8058468 Carbamate antibiotics  
The invention relates to the field of antibiotic compositions, both inside and outside the medical field. Presented is a new class of antibiotic compounds around the lead compound...
7563938 Alkylated aromatic compositions, zeolite catalyst compositions and processes for making the same  
The present invention is directed to novel alkylated aromatic compositions, zeolite catalyst compositions and processes for making the same. The catalyst compositions comprise zeolite Y and...
7560483 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof  
The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require...
7429658 Synthesis of protected pyrrolobenzodiazepines  
A method of synthesis of a N-10 protected PBD compound of formula (I): via an intermediate of formula (II) or formula (V):
7414145 Method of enantioselective nucleophilic addition reaction of enamide to carbonyl group and synthesis method of optically active α-hydroxy-γ-keto acid ester and hydroxydiketone  
A method of an enantioselective nucleophilic addition reaction to carbonyl, which enables an asymmetric synthesis of an optically active α-hydroxy-γ-keto acid ester, an optically active α...
7410965 Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol  
A delayed release pharmaceutical formulation containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol or a pharmaceutically acceptable salt thereof in a matrix; said matrix containing...
7312245 Diamine derivatives, process for producing the diamine derivatives, and fungicides containing the diamine derivatives as an active ingredient  
A fungicide can be provided by using, as an active ingredient, a diamine derivative of the following general formula (1): whereinR1 to R7 represent a specific substituent such as an alkyl group...
7253318 Benzyloxy derivatives as MAOB inhibitors  
The invention relates to compounds of the formula and their pharmaceutically acceptable salts wherein R1, R2, R3, R4, R5, n, m, and o are as defined in the specification. The compounds are...
RE39616 Aminoindan derivatives  
This invention is directed to compounds of the following formula: wherein when a is 0, b is 1 or 2; when a is 1, b is 1, m is from 0-3, X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is...
RE39593 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects  
1-phenyl-3-dimethylaminopropane compounds corresponding to the formula I a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions.
7041863 Zeolite Y alkylation catalysts  
The present invention is directed to a zeolite Y catalyst having a controlled macropore structure. The present invention is also directed to a zeolite Y catalyst composite and a process for...
7026515 Optically active amine derivatives and preparation process therefor  
A readily available and inexpensive natural α-amino acid is converted into a compound represented by formula (1), which is then reacted with an organometallic reagent represented by formula (2) to ...
6852738 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders  
A class of acyl sulfamides comprises compounds that are potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compounds may be useful in the treatment,...
6809207 Amino acid derivatives  
The present invention provides certain alpha-amino acids and derivatives thereof, such as, but not limited to, esters, amides and salts. These derivatives may comprise such representative side...
6803383 Inhibition of angiogenesis and tumor growth  
Compounds which inhibit tumor growth and angiogenesis, of general formula (II) are provided. These compounds include glycyl lysine derivatives bound to a central aromatic linking core.
6759511 Compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same  
The present invention relates to a carbonic acid ester compound of the following formula (1): in which X, Y, and Ar are defined in the specification, which can be easily combined with the amino...
6642406 Synthesis of N-&lsqb N-(3,3-dimethylbutyl)-L-α-aspartyl&rsqb -L-phenylalanine 1-methyl ester using L-α-aspartyl-L-phenylalanine 1-methyl ester precursors  
N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is produced by hydrogenation of a mixture of 3,3-dimethylbutyraldehyde and a precursor of L-α-aspartyl-L-phenylalanine 1...
6635621 Cysteine protease inhibitors  
This invention relates to derivatives of alpha-amino acid amides, to pharmaceutical compositions containing such compounds, and to their use in medicine as inhibitors of cysteine proteases,...
6620961 Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use  
Biarylalkylenecarbamic acid derivative represented by general formula (I): [wherein Q is a phenyl group which may be substituted or the like, X is a halogen atom, a (C1-C6) alkyl group or the like,...
6541653 Synthesis of carbamate through low pressure heterogeneous oxidative carbonylation of amines  
The process disclosed herein satisfies the need in the art for an industrially viable oxidative carbonylation catalytic system, and is capable of producing carbamates at a significantly higher rate...
6528678 Phosgene-free process for preparing carbamates  
A phosgene-free method for preparing a carbamate from a compound containing an amine group involves reacting the compound with an alkylating agent in the presence of carbon dioxide and cesium...
6455585 Esters derived from substituted phennyl-cyclohexyl compounds  
New esters derived from substituted phenyl-cyclohexyl compounds, which are derived from Tramadol, process for obtaining them and their use for preparing a drug with analgesic properties. These new...
6416686 Polyisocyanates  
Polyisocyanates are prepared by a process which comprises (i) preparation of an addition product (A) which contains one group which is reactive toward isocyanate and one isocyanate group by...
6414158 1,3,4-oxadiazine derivatives and their use as pesticides  
The invention relates to novel carbazate intermediates of formula (II), and to a process for their preparation, and their usefulness in the preparation of (1,3,4) oxadiazine derivatives useful as...
6350305 Selected polymeric furanone magenta colorants  
A polymeric furanone magenta colorant is disclosed that contains a furanone magenta chromophore having a furanone adduct, the adduct containing at least one alkoxylated phenyl radical, the...
6344558 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect  
1-phenyl-3-dimethylaminopropane compounds corresponding to the formula I a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions.
6335459 Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators  
This invention relates to compounds which are generally IP receptor modulators, particularly IP receptor agonists, and which are represented by Formula I: wherein R1, R2, R3, R4, R5, A, and B are...
6306873 Substituted β-thiocarboxylic acids  
This invention relates to compounds of general formula (I): ##STR1##in which Ar is a group selected from: ##STR2##A1, A2, B, C, D, E, Q1-Q3, R1-R9, Z1 and Z2 are as defined in the disclosure, and Y...
6235929 Tripeptide α-ketoamides  
A novel class of tripeptide α-ketoamides useful for selectively inhibiting serine proteases, selectively inhibiting cysteine proteases, generally inhibiting all serine proteases, and generally ...
6194458 Benzamide potassium channel inhibitors  
This invention relates to benzamide potassium channel inhibitors of general structural Formula I. ##STR1##The compounds of this invention are useful in the treatment of autoimmune diseases, the...
6180374 Method for preparing tert-leucine and analogues thereof in enantiomeric form and intermediates therein  
Azlactone (3), or the opposite enantiomer thereof, undergoes biotransformation, using suitable enzymatic activity, in the presence of a compound YH to form a N-acyl-amino acid (2), wherein R1, R2...
6174885 [6-(substituted-methyl)-3-cyclohexenyl] formamide derivative, hair growth promoter and external composition for skin  
A [6-(substituted-methyl)-3-cyclohexenyl]formamide derivative or a salt thereof expressed by the following Formula (I): ##STR1##wherein one of A and B is a hydrocarbon group of C10-30 expressed by...
6172108 Hydrazide compounds  
Compounds of formula (I): R--NH--A--CO--NH--NH--(W)n --Z (I)wherein: n is 0 or 1, W represents --CO-- or S(O)r wherein r is 0, 1 or 2, Z represents a group selected from aryl, arylalkyl, heteroaryl...
6169206 4-(n,n-dialkylamino)aniline compound, photographic processing composition containing the same and color image-forming method  
4-(N,N-Dialkylamino)aniline compounds of the following general formula (I): ##STR1##wherein R1 represents an alkyl group, an aryl group or a heterocyclic group, R2 to R5 each represent a hydrogen...
6143917 Process for producing aryl carbamates  
A process for producing an aryl carbamate of a high purity at a high yield by reacting a diaryl carbonate with an amine compound having one or more hydrogen atoms bonded to the N position in the...
6114325 1,2-di-substituted benzene-carboxamide derivative, hair growth promoter and external composition for skin using the same  
A 1,2-di-substituted benzene-carboxamide derivative or a salt thereof expressed by the following Formula (I); ##STR1## wherein each of A and B is R1 or --(CH2)n-NR2 R3, wherein when A is R1, B is...
6096836 (Hetero)aromatic ether, (thio)ester or (thio)carbonate epoxy catalyst  
Disclosed herein is a curing catalyst comprising at least one compound which is a substituted or unsubstituted aromatic or heteroaromatic compound and having any one of groups (I) --O--R1, (II)...
6080784 Protein kinase C modulators N  
Compositions with protein kinase C-modulatory, anti-inflammatory and other activities are disclosed.
6057269 Benzylhydroxylamines and intermediates used to prepare them  
Benzylhydroxylamines I ##STR1## (X=--N(R7)--O--; Y=O, S; R1 =halogen, CN, NO2, CF3 ; R2 =H, halogen; R3 =H, NH2, CH3 ; R4 =H, halogen, C1 -C6 -alkyl, C1 -C6 -haloalkyl, C1 -C6 -alkylthio, C1 -C6...
6043284 Anti-atherosclerotic diaryl compounds  
The present invention is concerned with diaryl compounds of formula (I) and their use in medical therapy, particularly in the prophylaxis or treatment of a clinical condition for which an ACAT...
6013606 Substituted cinnamic oxime and hydroxamide derivatives  
Substituted cinnamic oxime derivatives I and cinnamic hydroxamide derivatives II ##STR1## (R1= halogen, NO2, CN, CF3 ; R2 =H, halogen; R3= H, halogen, C1 -C6 -alkyl, C1 -C6 -haloalkyl, C3 -C6...
5985919 (Het)aryloxy-, -thio- , aminocrotonates, methods of preparing them and their use as insecticides and fungicides  
(Het)aryloxy-, -thio- and -aminocrotonates of the formula I ##STR1## where the substituents have the following meanings: U is oxygen, sulfur or amino; V is oxygen, sulfur, amino or alkylamino; X, Y...
5977398 Viscosity conditioner  
A viscosity conditioner is disclosed which is comprised of a compound represented by the following formula ##STR1## where R1 to R3 each are hydrocarbyl groups which may be identical or different, m...
5891916 Aromatic hydroxamix acid compounds, their production and use  
A compound represented by the formula: ##STR1## wherein Ar1 and Ar2 independently represent an optionally substituted aromatic group; Q represents an optionally substituted divalent aliphatic...
5837873 Intermediates of retroviral protease inhibiting compounds  
A retroviral protease inhibiting compound of the formula A--X--B is disclosed. Also disclosed are a composition and method for inhibiting a retroviral protease and for treating an HIV infection....
5780585 Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form  
A prodrug of the formula (I): ##STR1## where R1 is a group such that the compound R--NH2 represents actinomycin D, doxorubicin, mitomycin C, or a nitrogen mustard of the formula (IV): ##STR2## a...
5756817 O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same  
The present invention relates to a racemic or enantiomerically enriched O-carbamoyl-phenylalaninol compound represented by the following structural formula V and pharmaceutically acceptable salts...
5750696 Dioxacycloalkane compound having renin-inhibitory activity  
Dioxacycloalkane compounds of the formula 1! ##STR1## wherein A is ##STR2## wherein W is ##STR3## X is --CO-- or --SO2 --; Y is --CH2 --, --O-- or --NR25 --; and R1 is an aralkyl which may be...
5728588 Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands  
A surface of specific reactivity is formed by adsorbing a modified block polymeric surfactant of the Pluronic-type, i.e., containing pendant poly(ethylene oxide) blocks attached at an end to...
5705521 Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors  
A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The effect has particular application in radiation oncology applications. The...